tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AVBP Stock Latest News

ArriVent Biopharma price target raised to $36 from $30 at Citi
The FlyArriVent Biopharma price target raised to $36 from $30 at Citi
9d ago
AVBP
ArriVent Biopharma price target raised to $39 from $35 at Oppenheimer
PremiumThe Fly
ArriVent Biopharma price target raised to $39 from $35 at Oppenheimer
10d ago
AVBP
ArriVent Biopharma price target raised to $36 from $30 at H.C. Wainwright
PremiumThe Fly
ArriVent Biopharma price target raised to $36 from $30 at H.C. Wainwright
10d ago
AVBP
ArriVent announces PoC global Phase 1b interim data for firmonertinib
PremiumThe Fly
ArriVent announces PoC global Phase 1b interim data for firmonertinib
11d ago
AVBP
Corbus Pharmaceuticals appoints Kung to board of directors
PremiumThe Fly
Corbus Pharmaceuticals appoints Kung to board of directors
1M ago
AVBP
CRBP
ArriVent Biopharma price target raised to $30 from $25 at H.C. Wainwright
PremiumThe FlyArriVent Biopharma price target raised to $30 from $25 at H.C. Wainwright
1M ago
AVBP
ArriVent Biopharma reports Q2 EPS (65c), consensus (64c)
Premium
The Fly
ArriVent Biopharma reports Q2 EPS (65c), consensus (64c)
1M ago
AVBP
ArriVent BioPharma Reports Second Quarter 2024 Financial Results
Premium
Press Releases
ArriVent BioPharma Reports Second Quarter 2024 Financial Results
1M ago
AVBP
ArriVent to Present Proof-Of-Concept Phase 1b Data for Firmonertinib in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2024 World Conference on Lung Cancer
PremiumPress Releases
ArriVent to Present Proof-Of-Concept Phase 1b Data for Firmonertinib in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2024 World Conference on Lung Cancer
1M ago
AVBP
ArriVent Biopharma initiated with an Outperform at Oppenheimer
PremiumThe Fly
ArriVent Biopharma initiated with an Outperform at Oppenheimer
2M ago
AVBP
PremiumCompany Announcements
ArriVent BioPharma’s Strategic Alliance for Cancer Drug Development
4M ago
8K
AVBP
ArriVent Announces a Multi-Target ADC Collaboration with Alphamab
PremiumPress Releases
ArriVent Announces a Multi-Target ADC Collaboration with Alphamab
4M ago
AVBP
ArriVent Biopharma announces multi-target ADC collaboration with Alphamab
PremiumThe FlyArriVent Biopharma announces multi-target ADC collaboration with Alphamab
4M ago
AVBP
Premium
Company Announcements
ArriVent BioPharma Welcomes Dr. Hohneker to Board
4M ago
8K
AVBP
ArriVent Appoints John Hohneker, M.D., to its Board of Directors
Premium
Press Releases
ArriVent Appoints John Hohneker, M.D., to its Board of Directors
4M ago
AVBP
ArriVent BioPharma Reports First Quarter 2024 Financial Results
PremiumPress Releases
ArriVent BioPharma Reports First Quarter 2024 Financial Results
5M ago
AVBP
ArriVent Biopharma reports Q1 EPS (70c), consensus ($1.10)
PremiumThe Fly
ArriVent Biopharma reports Q1 EPS (70c), consensus ($1.10)
5M ago
AVBP
ArriVent Biopharma initiated with a Buy at H.C. Wainwright
PremiumThe Fly
ArriVent Biopharma initiated with a Buy at H.C. Wainwright
5M ago
AVBP
PremiumCompany Announcements
ArriVent BioPharma Welcomes Kristine Peterson to Board
5M ago
8K
AVBP
ArriVent Appoints Kristine Peterson to its Board of Directors
PremiumPress ReleasesArriVent Appoints Kristine Peterson to its Board of Directors
5M ago
AVBP
Drugmakers look to alternative suppliers after draft U.S. legislation, FT says
Premium
The Fly
Drugmakers look to alternative suppliers after draft U.S. legislation, FT says
5M ago
LLY
AVBP
ArriVent BioPharma Reports Full Year 2023 Financial Results
Premium
Press Releases
ArriVent BioPharma Reports Full Year 2023 Financial Results
6M ago
AVBP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >